Trial Profile
Clinical Trials Insight: 700028489
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 15 Nov 2007
Price :
$35
*
At a glance
- Drugs Ortataxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Spectrum Pharmaceuticals
- 15 Nov 2007 New trial record.